Acro Biomedical
(OTC) ACBM
Acro Biomedical Financials at a Glance
Market Cap
$1.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$134.62K
EPS (TTM)
-$0.00
P/E Ratio
-11.82
Dividend
$0.00
Beta (Volatility)
-2.49 (Low)
Dividend
$0.00
Beta (Volatility)
-2.49 (Low)
Price
$0.03
Volume
260
Open
$0.03
Price
$0.03
Volume
260
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
Nov 19, 2024
Dividend
$0.00
Beta (Volatility)
-2.49 (Low)
Price
$0.03
Volume
260
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
Nov 19, 2024
ACBM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acro Biomedical
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
1
CEO
Yu-Ting Su
Website
www.acrobiomedicalco.comHeadquarters
Fishers, IN 46038, US
ACBM Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
34.42%
Return on Capital
N/A
Return on Assets
-3475.83%
Earnings Yield
-8.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
60.04M
Volume
260
Avg. Volume
6.694
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$205.36K
EBITDA
-$205.36K
Operating Cash Flow
-$223.59K
Capital Expenditure
-$3.00
Free Cash Flow
-$223.59K
Cash & ST Invst.
$3.87K
Total Debt
$375.11K
Acro Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.56M
N/A
Employees
1
N/A
Net Income
-$43.77K
-324.9%
EBITDA
-$60.27K
-574.6%
Quarterly Fundamentals
Total Cash
$3.87K
+1443.0%
Total Debt
$375.11K
+126.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$375.11K
+126.1%
Return on Assets
-34.76%
N/A
Return on Invested Capital
48.07%
N/A
Free Cash Flow
-$49.82K
-121.1%
Operating Cash Flow
-$49.82K
-121.1%